Psychedelics Company Silo Wellness Expands its Shareholder Base to Europe by Commencing Trading on the German Börse Frankfurt Exchange Under Ticker Symbol “3K70”

- April 12th, 2021

Silo Wellness Inc. a wellness company in the psychedelics and functional mushroom marketplaces is pleased to announce that trading of its common shares has expanded to include overseas listing on the German Börse Frankfurt exchange platform. The commons shares of Silo Wellness securities began trading on Friday, April 9, 2021 on the FRA under ticker symbol 3K70 and registered under WKN: A2QQTP andor ISIN: …

Silo Wellness Inc. (CSE:SILO) (FRA:3K70), a wellness company in the psychedelics and functional mushroom marketplaces is pleased to announce that trading of its common shares has expanded to include overseas listing on the German Börse Frankfurt (FRA) exchange platform.

The commons shares of Silo Wellness securities began trading on Friday, April 9, 2021 on the FRA under ticker symbol 3K70 and registered under WKN: A2QQTP and/or ISIN: CA8271241082.

“Expanding our shareholder base more broadly into the European market by commencing trading on the Frankfurt exchange is an important milestone for Silo Wellness as we continue to broaden our international presence,” said Douglas K. Gordon, Chief Executive Officer of Silo Wellness.  “By listing on the FRA, a wider audience of investors will now be able to actively participate in the growth of Silo Wellness as we continue to deliver on our mission as well as grow on a global basis.”

About Silo Wellness
The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion. Silo Wellness intends to introduce new, safe and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal by conducting ketamine and psilocybin wellness retreats and elsewhere by manufacturing and distributing functional mushrooms.

Since its inception, Silo Wellness’ activities have focused on: (1) development of psilocybin-free functional mushroom tinctures; (2) the development of the formulation of a psilocybin nasal spray in Jamaica; and (3) offering of Jamaican and Oregon psychedelic wellness retreats as well as the cultivation of psychedelic mushrooms in Jamaica. None of Silo Wellness’ products claim to cure or mitigate any physical or mental disease, symptoms, disorders or abnormalities.

For further information, please contact: www.SiloWellness.com

Silo Wellness Investor Relations:
(604) 343-2724
IR@empiregroupir.com

Media Relations:
Stuart Kirby, VP of Marketing & Communications
press@silowellness.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION :

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “ forward-looking statements ”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: listing of the common shares of Silo Wellness on the CSE and the business plans of Silo Wellness. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties and the potential impact of COVID-19. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Readers should not place undue reliance on the forward-looking statements and information contained in this news release. Silo Wellness assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Tags

Tags:

Leave a Reply